swissbiotech.org
Polyphor AG
Polyphor, a clinical stage biopharmaceutical company, focuses on the development of new antibiotics against Gram-negative bacteria with its Outer Membrane Protein Targeting Antibiotic (OMPTA) platform. Polyphor is also developing an immuno-oncology candidate to improve therapy outcomes in cancer.